| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |